Estimating the effect of tocilizumab compared to etanercept on cardiovascular risk in rheumatoid arthritis
A new-user cohort study comparing tocilizumab to etanercept on cardiovascular risk in rheumatoid arthritis. The idea was to replicate this trial, but currently we don't have enough sample if we implement the same criteria as used in the trial.
...
Suspended (may be restarted when there is more data)